Anplag


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 13.4%
Atrial Fibrillation 8.7%
Arteriosclerosis Obliterans 7.9%
Cerebral Infarction 5.5%
Angina Pectoris 4.7%
Atypical Mycobacterial Infection 4.7%
Disease Complication 4.7%
Hypoaesthesia 4.7%
Pain 4.7%
Product Used For Unknown Indication 4.7%
Cardiovascular Disorder 3.9%
Hepatitis B 3.9%
Hypertension 3.9%
Osteoporosis 3.9%
Parkinson's Disease 3.9%
Scleroderma 3.9%
Aortic Valve Atresia 3.1%
Chondritis 3.1%
Hyperlipidaemia 3.1%
Pneumonia 3.1%
Liver Disorder 14.6%
Haemoglobin Decreased 9.8%
Hepatitis 9.8%
Interstitial Lung Disease 9.8%
Pneumonia 9.8%
Dermatitis Exfoliative 7.3%
Melaena 4.9%
Renal Impairment 4.9%
Abdominal Pain Upper 2.4%
Activated Partial Thromboplastin Time Prolonged 2.4%
Cerebral Infarction 2.4%
Drug Ineffective 2.4%
Dysuria 2.4%
Fat Embolism 2.4%
Gastroenteritis 2.4%
Generalised Erythema 2.4%
Malaise 2.4%
Neoplasm Progression 2.4%
Occult Blood 2.4%
Osteomyelitis 2.4%
Concomitant
Hypertension 20.5%
Product Used For Unknown Indication 8.7%
Rheumatoid Arthritis 8.2%
Arteriosclerosis Obliterans 7.6%
Prophylaxis 7.2%
Angina Pectoris 5.3%
Drug Use For Unknown Indication 4.7%
Insomnia 4.4%
Gastritis 4.3%
Constipation 4.2%
Diabetes Mellitus 3.7%
Type 2 Diabetes Mellitus 3.1%
Osteoporosis 2.7%
Atrial Fibrillation 2.6%
Pain 2.4%
Hyperphosphataemia 2.2%
Cardiac Failure Chronic 2.2%
Herpes Zoster 2.2%
Hyperuricaemia 2.1%
Hyperlipidaemia 1.9%
Death 7.6%
Pyrexia 7.6%
Hypoglycaemia 6.4%
Renal Impairment 6.4%
Cerebral Infarction 5.7%
Somnolence 5.7%
Tremor 5.7%
Insomnia 5.1%
Interstitial Lung Disease 5.1%
Pneumonia 5.1%
Rhabdomyolysis 5.1%
Cardiac Failure Chronic 4.5%
Hepatitis Fulminant 4.5%
Hepatic Function Abnormal 3.8%
Loss Of Consciousness 3.8%
Myocardial Infarction 3.8%
Platelet Count Decreased 3.8%
Vomiting 3.8%
Cardiac Failure 3.2%
Nephrotic Syndrome 3.2%

Drug Data